ERBB2 and breast cancer: In BC organoids, the HER2 signaling pathway is typically aberrantly activated through heterodimerization with other HER family members, activating downstream pathways such as Ras/Raf/MEK/ERK and PI3K/AKT/mTOR, which promotes tumor cell proliferation, migration, and invasion [233, 234].